Work

NAMPT Inhibitor KPT-9274 Selectively Targets Self-Renewal Capacity in Acute Myeloid Leukemia

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-119358

Authors: Shaneice Renee Mitchell, Nicole Grieselhuber, Yerdanos Asemelash, Matthew Cannon, Shelley Orwick, Pratibha Sharma, Virginia Goettl, Vinay K Puduvalli, Deepa Sampath, Alice S. Mims, James S. Blachly, Amy M. Lehman, Bonnie K. Harrington, Justin Breitbach, Erkan Baloglu, William Senapedis, Rosa Lapalombella, John C. Byrd

Institutions: The Ohio State University, Karyopharm Therapeutics (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2903368671

Cites:

Cited by:

Related to: 10